Table 1.
Clinical and Metabolic Characteristics among PA and EHC subjects
| PA (n=21) | EHC (n=22) | p-value | |
|---|---|---|---|
| Age (yr) | 53.9 ± 2.6 | 51.8 ± 2.6 | 0.58 |
| Sex (Female, n) | 12 | 13 | |
| Body mass index (kg/m2) | 29.9 ± 1.3 | 32.5 ± 1.7 | 0.24 |
| Systolic blood pressure (mmHg) | 137.0 ± 2.7 | 135.7 ± 4.0 | 0.81 |
| Diastolic blood pressure (mmHg) | 82.0 ± 2.7 | 79.1 ± 3.0 | 0.52 |
| Mean arterial pressure (mmHg) | 100.2 ± 2.6 | 97.8 ± 3.4 | 0.59 |
| Total cholesterol (mg/dL) | 160.7 ± 6.2 | 183.2 ± 10.5 | 0.09 |
| LDL cholesterol (mg/dL) | 92.4 ± 6.5 | 106 ± 8.0 | 0.20 |
| HDL cholesterol (mg/dL) | 50.0 ± 4.7 | 55.7 ± 3.7 | 0.34 |
| Triglycerides (mg/dL) | 90.6 ± 7.1 | 108.0 ± 19.0 | 0.41 |
| Fasting plasma glucose (mg/dL) | 89.7 ± 1.9 | 91.1 ± 1.7 | 0.59 |
| Fasting plasma insulin (mU/L) | 12.8 ± 2.1 | 9.0 ± 1.5 | 0.18 |
| Hemoglobin A1C (%) | 5.4 ± 0.07 | 5.6 ± 0.07 | 0.04 |
| BUN (mg/dL) | 14.7 ± 1.0 | 15.4 ± 0.9 | 0.64 |
| Creatinine (mg/dL) | 0.9 ± 0.04 | 0.8 ± 0.04 | 0.62 |
| Sodium (mEqmol/L) | 135.7 ± 6.1 | 138.9 ± 0.4 | 0.61 |
| Potassium (mEqmol/L) | 3.7 ± 0.1 | 4.0 ± 0.05 | 0.06 |
Data are presented as arithmetic mean ± SEM; n, no. of subjects. P values indicate statistical significance for comparisons between groups. EHC, essential hypertensive controls; PA, primary aldosteronism; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; BUN, blood urea nitrogen.